ROCKB:BXROCKWOOL A/S Class B Analysis
Data as of 2026-03-15 - not real-time
DKK 186.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Rockwool A/S is trading well below its 20‑day (≈203) and 50‑day (≈213) simple moving averages, signaling a bearish price trend, while the 14‑day RSI sits near 29, indicating oversold conditions. Technical momentum is further weakened by a bearish MACD histogram and a price that remains above the identified support at roughly 177 DKK but far from the 226.75 DKK resistance. Fundamentally, the stock appears dramatically overvalued – a trailing P/E of over 250 versus an industry average of ~29 and a DCF‑derived fair value of just 5.2 DKK – and it delivers modest profit margins (≈0.7% net) despite solid gross profitability. The dividend yield of 2.23% is supported by an extremely low payout ratio (~8%), suggesting sustainability, but the company’s growth is flat (‑0.3% revenue YoY) and its return metrics are weak. Recent news of a corporate share‑class conversion and an upgrade by UBS to “buy” on margin provide a minor positive catalyst, yet the overall valuation gap and bearish technical setup dominate the outlook.
Investors should therefore treat ROCKB as a high‑priced, low‑growth industrial with limited upside potential in the near to medium term, while the dividend remains a modest, sustainable income stream.
Investors should therefore treat ROCKB as a high‑priced, low‑growth industrial with limited upside potential in the near to medium term, while the dividend remains a modest, sustainable income stream.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages indicating bearish momentum
- RSI in oversold territory suggesting potential short‑term bounce
- Increasing volume despite thin overall trading activity
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistently high valuation relative to earnings and DCF fair value
- Flat revenue growth and low net margins
- Sustained dividend with very low payout ratio
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Extreme overvaluation that is unlikely to be justified by fundamentals
- Weak profitability and minimal ROE/ROA
- High price volatility and limited upside beyond current support levels
Key Metrics & Analysis
Financial Health
Revenue Growth-0.30%
Profit Margin0.72%
P/E Ratio251.4
ROE0.96%
ROA9.86%
Debt/Equity10.07
P/B Ratio1.9
Op. Cash FlowDKK610.0M
Free Cash FlowDKK91.0M
Industry P/E29.1
Technical Analysis
TrendBearish
RSI28.9
SupportDKK 176.91
ResistanceDKK 226.75
MA 20DKK 203.64
MA 50DKK 212.59
MA 200DKK 243.42
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueDKK 5.16
GradeOvervalued
TypeValue
Dividend Yield2.23%
Risk Assessment
Beta0.42
Volatility39.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.